The illusion of "optimal" platelet inhibition

JACC: Cardiovascular Interventions

Volumn 5, Issue 3, 2012, Pages 278-280

  Steinhubl, Steven R ^a  

^a GEISINGER HEALTH SYSTEM   (United States)

Author keywords

aggregometry; clopidogrel; glycoprotein (GP) IIb IIIa inhibitors; platelet function testing; platelets

Indexed keywords

ADENOSINE DIPHOSPHATE; ANTITHROMBOCYTIC AGENT; CITRIC ACID; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRUDIN; PURINERGIC P2Y12 RECEPTOR; THIENOPYRIDINE DERIVATIVE;

ANTICOAGULATION; ARTERY THROMBOSIS; ATHEROSCLEROSIS; BLEEDING; BLOOD CLOTTING PARAMETERS; HEART INFARCTION; HUMAN; NOTE; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGLUTINATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE INHIBITION; THROMBOCYTE RICH PLASMA;

EID: 84858780356     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2012.02.002     Document Type: Editorial

References (15)

1. The Analects of Confucius Translated by Arthur Waley 1938 The Macmillan Company New York
2. S.R. Steinhubl Historical observations on the discovery of platelets, platelet function testing and the first antiplatelet agent Curr Drug Targets 12 2011 1792 1804
3. E. Panak, J.P. Maffrand, C. Picard-Fraire, E. Vallee, J. Blanchard, R. Roncucci Ticlopidine: a promise for the prevention and treatment of thrombosis and its complications Haemostasis 13 Suppl 1 1983 1 54
4. N.S. Kleiman, A.E. Raizner, R. Jordan Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 fab: implications for inhibition of the internal pool of GPIIb/IIIa receptors J Am Coll Cardiol 26 1995 1665 1671
5. J.A. Cairns, M. Gent, J. Singer Aspirin, sulfinpyrazone, or both in unstable angina: results of a Canadian multicenter trial N Engl J Med 313 1985 1369 1375 (Pubitemid 16211835)
6. J.C. Rosenberg, T.L. Sell In vitro evaluation of inhibitors of platelet release and aggregation Arch Surg 110 1975 980 983
7. L.K. Newby, R.M. Califf, H.D. White The failure of orally administered glycoprotein IIb/IIIa inhibitors to prevent recurrent cardiac events Am J Med 112 2002 647 658 (Pubitemid 34597166)
8. D.L. Bhatt, A.M. Lincoff, C.M. Gibson Intravenous platelet blockade with cangrelor during PCI N Engl J Med 361 2009 2330 2341
9. R.A. Harrington, G.W. Stone, S. McNulty Platelet inhibition with cangrelor in patients undergoing PCI N Engl J Med 361 2009 2318 2329
10. P. Tricoci, Z. Huang, C. Held Thrombin-receptor antagonist vorapaxar in acute coronary syndromes N Engl J Med 366 2012 20 33
11. M. Gawaz, F.J. Neumann, I. Ott, A. Schiessler, A. Schomig Platelet function in acute myocardial infarction treated with direct angioplasty Circulation 93 1996 229 237 (Pubitemid 26031479)
12. S.G. Ahn, S.-H. Lee, J.-H. Yoon et al. Different prognostic significance of high on-treatment platelet reactivity as assessed by the VerifyNow P2Y12 assay after coronary stenting in patients with and without acute myocardial infarction J Am Coll Cardiol Intv 5 2012 259 267
13. M. Valgimigli, G. Tebaldi, G. Campo et al. Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: The FABOLUS PRO (Facilitation through Aggrastat By drOpping or shortening Infusion Line in patients with ST-segment elevation myocardial infarction compared to or on top of PRasugrel given at loading dOse) trial J Am Coll Cardiol Intv 5 2012 268 277
14. J. Mehilli, A. Kastrati, S. Schulz Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial Circulation 119 2009 1933 1940
15. R.P. Giugliano, J.A. White, C. Bode Early versus delayed, provisional eptifibatide in acute coronary syndromes N Engl J Med 360 2009 2176 2190